How different ways of defining iron deficiency (ID) impact the prevalence estimates of this common disorder among women.
Cognition Therapeutics’ stock sinks on Phase 2 Alzheimer’s data
New Alzheimer’s data from Cognition Therapeutics appeared to show an early drug effect, but one that lessened over time. Cognition presented Phase 2 results from